130 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
, and potential access to further funding after the date of this release. Forward-looking statements are subject to certain risks and uncertainties inherent
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
not have access to a therapy to treat this life altering condition
Research Triangle Park, N.C. and Uxbridge, United Kingdom, March 18, 2024 – Fennec … enabling creative solutions to bring life-changing medicines to patients that they may not otherwise be able to access. Norgine is proud to have helped
8-K
EX-10.1
7jac0os akd3xi8wdlw
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B7
wrh8ol
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K/A
EX-99.1
ua41v0wef6k7
6 Mar 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:07pm
8-K
EX-99.1
04p98z4u2zz
29 Feb 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:04pm
8-K
EX-99.1
3habdvd
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K
EX-99.1
u72oj58bfnvj9dc
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-99.1
kcz62wlp
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
tbs90u2ih3vu7503 dgc
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
bpdszaqcuwqw zf5922i
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
EX-99.1
nucpr5ovgv4shj8c1aj
6 Jun 23
Other Events
5:39pm